RK STRATEGIES, INC. lobbying for CLEARMIND MEDICINE, INC

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

British Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Health Issues

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY27 National Defense Authorization Act, FY27

Defense

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY27 National Defense Authorization Act, FY27 Other Psychedelic Legislation

Alcohol and Drug Abuse

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY27 National Defense Authorization Act, FY27 Other Psychedelic Legislation

Veterans

H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY27 National Defense Authorization Act, FY27 Other Psychedelic Legislation

Bills named in this filing 2

H.R. 7091
Expanding Veterans’ Access to Emerging Treatments Act
H.R. 2623
Innovative Therapies Centers of Excellence Act of 2025